Cefdinir

Product NDC
53002-1526
11-digit product format
530021526
Labeler code
53002
Product ID
53002-1526_7e4ab69e-495d-4b51-bb1f-4f92b46b6d2e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cefdinir
Dosage form
CAPSULE
Route
ORAL
Labeler
RPK Pharmaceuticals, Inc.
Application
ANDA065434
Marketing category
ANDA
Marketing start
2008-01-07
Marketing end
0000-00-00
Substance
CEFDINIR
Active strength
300 mg/1
Pharmacologic classes
Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d3e72f63-2c41-955f-f4ce-e90c6403e67cProduct name220210729
e8e66e64-d220-99cb-44eb-0f32dc8cbda1Product name220210729

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53002-1526-1Cefdinir10 in 1 BOTTLECAPSULE105
53002-1526-2Cefdinir20 in 1 BOTTLECAPSULE205

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53002-1526CEFDINIR CAPSULE [RPK PHARMACEUTICALS, INC.]5Legacy NDC, 2 package rows20230609_064e3f74-9644-49bd-abef-20e1dd97794e.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
200346cefdinir 300 MG Oral CapsulePSN064e3f74-9644-49bd-abef-20e1dd97794e5
200346cefdinir 300 MG Oral CapsuleSCD064e3f74-9644-49bd-abef-20e1dd97794e5

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
53002-1526-15300215260110 CAPSULE in 1 BOTTLE (53002-1526-1) 10 capsule2018-10-010000-00-00NoNoCurrent
53002-1526-25300215260220 CAPSULE in 1 BOTTLE (53002-1526-2) 20 capsule2018-10-010000-00-00NoNoCurrent